📰 Ryan Bariola News
Ryan Bariola News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ryan Bariola. Real-time updates on events, politics, business and more.
October 19, 2022
PITTSBURGH, PA, Oct. 19, 2022 (GLOBE NEWSWIRE) -- As a world leader in telemedicine-enabled Infectious Diseases (ID) care, antimicrobial stewardship, and...
January 5, 2022
During a Tuesday discussion hosted by the Pennsylvania Department of Health, doctors stressed one message: Get the COVID-19 vaccination.
October 2, 2021
Local doctors said a pill to treat covid-19 could help keep patients healthy and ease the burden on overstrained hospitals, though they’re eyeing the drug with cautious optimism while awaiting final data. Merck & Co. on Friday announced its experimental pill cut hospitalizations and deaths in half for people recently
May 17, 2021
Monoclonal antibodies, a COVID-19 treatment given early after coronavirus infection, cut the risk of hospitalization and death by 60% in those most...
May 17, 2021
E-Mail IMAGE: Associate professor in Pitts Division of Infectious Diseases and director of the UPMC Community Hospital Antimicrobial Stewardship Efforts (CHASE) Program. view more Credit: UPMC PITTSBURGH, May 17, 2021 - Monoclonal antibodies, a COVID-19 treatment given early after coronavirus infection, cut the risk of hospitalization and death by 60% in those most likely to suffer complications of the disease, according to an analysis of UPMC patients who received the medication co...
April 13, 2021
The Philadelphia Inquirer Star Tribune Vials are inspected at Regeneron Pharmaceutical’s facilities in New York state, for efforts on an experimental coronavirus antibody drug. TribLIVEs Daily and Weekly email newsletters deliver the news you want and information you need, right to your inbox. PHILADELPHIA — Drugs that can keep high-risk covid-19 patients out of the hospital are going begging because the supposed breakthrough treatments require an hour-long intravenous infusion and offe...
December 22, 2020
Low Demand For Antibody Drugs Against COVID-19 Update RequiredTo play audio, update browser or Flash plugin. President Trump boards Marine One for a trip from the White House to Walter Reed National Military Medical Center for COVID-19 treatment in early October. Trump received Regenerons antibody cocktail during his illness. Alex Brandon / AP Federal officials are disappointed to find that the monoclonal antibody drugs theyve shipped across the country arent being used rapidly. T...
December 22, 2020
/ President Trump boards Marine One for a trip from the White House to Walter Reed National Military Medical Center for COVID-19 treatment in early October. Trump received Regenerons antibody cocktail during his illness. // AP, Alex Brandon Federal officials are disappointed to find that the monoclonal antibody drugs theyve shipped across the country arent being used rapidly. These drugs are designed to prevent people recently diagnosed with COVID-19 from ending up in the hospital. But...
December 22, 2020
Alex Brandon/AP toggle caption Alex Brandon/AP President Trump boards Marine One for a trip from the White House to Walter Reed National Military Medical Center for COVID-19 treatment in early October. Trump received Regenerons antibody cocktail during his illness. Alex Brandon/AP Federal officials are disappointed to find that the monoclonal antibody drugs theyve shipped across the country arent being used rapidly. These drugs are designed to prevent peo...
December 22, 2020
Low Demand For Antibody Drugs Against COVID-19 Federal officials are disappointed to find that the monoclonal antibody drugs theyve shipped across the country arent being used rapidly. These drugs are designed to prevent people recently diagnosed with COVID-19 from ending up in the hospital. But hospitals are finding it cumbersome to use these medicines, which must be given by IV infusion. And some patients and doctors are lukewarm about drugs that have an uncertain benefit. The Food and Drug A...